LSL Pharma Group Inc. (TSXV:LSL)
0.4100
+0.0150 (3.80%)
At close: Apr 10, 2026
24.24% (1Y)
| Market Cap | 49.70M +30.4% |
| Revenue (ttm) | 26.80M +69.4% |
| Net Income | 2.78M |
| EPS | 0.02 |
| Shares Out | 121.22M |
| PE Ratio | 18.07 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 40,620 |
| Average Volume | 87,399 |
| Open | 0.4100 |
| Previous Close | 0.3950 |
| Day's Range | 0.4000 - 0.4100 |
| 52-Week Range | 0.3100 - 0.5600 |
| Beta | -0.48 |
| RSI | 49.61 |
| Earnings Date | Feb 27, 2026 |